Regen BioPharma Inc Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q1 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Regen BioPharma Inc quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q1 2014 to Q3 2024.
  • Regen BioPharma Inc Deferred Tax Assets, Valuation Allowance for the quarter ending September 30, 2024 was $4.33M, a 4.39% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $4.33M +$182K +4.39% Sep 30, 2024 8-K 2024-11-29
Q3 2023 $4.15M -$243K -5.53% Sep 30, 2023 10-K 2023-11-20
Q3 2022 $4.39M -$513K -10.5% Sep 30, 2022 10-K 2022-11-15
Q3 2021 $4.9M +$1.42M +40.8% Sep 30, 2021 10-K 2021-12-22
Q3 2020 $3.48M -$717K -17.1% Sep 30, 2020 10-K 2021-08-04
Q3 2019 $4.2M +$534K +14.6% Sep 30, 2019 10-K 2021-06-21
Q4 2018 $3.6M -$1.68M -31.9% Dec 31, 2018 10-Q 2019-02-12
Q3 2018 $3.67M -$666K -15.4% Sep 30, 2018 10-K 2018-12-27
Q2 2018 $3.46M -$445K -11.4% Jun 30, 2018 10-Q 2018-08-06
Q1 2018 $3.5M +$483K +16% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 $5.28M -$2.46M -31.7% Dec 31, 2017 10-Q 2018-02-06
Q3 2017 $4.33M -$2.54M -37% Sep 30, 2017 10-K 2018-01-05
Q2 2017 $3.91M -$2.14M -35.4% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 $3.02M -$2.23M -42.5% Mar 31, 2017 10-Q 2017-05-05
Q4 2016 $7.73M +$2.86M +58.7% Dec 31, 2016 10-Q/A 2017-04-28
Q3 2016 $6.88M +$2.64M +62.1% Sep 30, 2016 10-K/A 2017-04-28
Q2 2016 $6.04M +$2.01M +49.7% Jun 30, 2016 10-Q/A 2017-04-28
Q1 2016 $5.24M +$1.74M +49.6% Mar 31, 2016 10-Q/A 2017-04-28
Q4 2015 $4.87M +$5.38M Dec 31, 2015 10-Q/A 2017-04-28
Q3 2015 $4.24M +$4.68M Sep 30, 2015 10-K/A 2017-04-28
Q2 2015 $4.04M +$4.41M Jun 30, 2015 10-Q/A 2017-04-28
Q1 2015 $3.51M +$3.82M Mar 31, 2015 10-Q/A 2017-04-28
Q4 2014 -$509K Dec 31, 2014 10-Q 2015-02-04
Q3 2014 -$435K Sep 30, 2014 10-K 2014-12-18
Q2 2014 -$369K Jun 30, 2014 10-Q 2014-08-07
Q1 2014 -$312K Mar 31, 2014 10-Q 2014-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.